IP Verse

Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof - EP3782611

PATENT ANALYSIS

Patent Details

Grant Date
Jul 6, 2022
Company
CELGENE CORPORATION
Oppositions

HAMM&WITTKOPP PATENTANWALTE PARTMBB

SANDOZ AG

STADA ARZNEIMITTEL AG

SYNTHON BV

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Celgene Corporation

EP3370729

EP2651400

EP3880802

Want to monitor this patent?

Feel free to send us a message here and we will get back to you